• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Incyte Corp

NASDAQ:INCY

$22.41 -$0.25 (-1.10%)

REAL-TIME: Last trade at

Cramer's Lightning Round - Titan Is In-Your-Face Optimistic (5/23/12)

Incyte Stays Neutral - Analyst Blog

Incyte Stays Neutral - Analyst Blog

Investing 101: Biotech Stocks With Insider Buying

Weekly CEO Sells Highlight: DIS, LMT, INCY, ADBE

A Much-Needed Win for Pfizer

Loss at Incyte Widens on Higher Costs - Analyst Blog

Is This Biotech Trying to Distract Investors?

The Stock Market's Biggest Winners This Week

Why Incyte Shares Popped

Great Deal. Now What?

Incyte Upped to Neutral - Analyst Blog

These Cold Stocks Are Heating Up

Make Money in Biotech and Genome Stocks the Easy Way

Will Abbott Labs Help You Retire Rich?

Incyte Cut to Underperform - Analyst Blog

Drab Quarter at Incyte, Shares Down - Analyst Blog

Incyte in Neutral Lane - Analyst Blog

Do the Shorts Know Something You Don't?

JPMorgan Confab Kicks Off Biotech 2012

Tomorrow's Monster Stock

Is YM the Next Incyte?

YM Biosciences Rises on Promising Study Data for Blood Drug

You're Not the Only One Buying Here

Applications Given Early Antitrust Clearance

Wall Street's Best Hidden Stocks

2 Stocks Approaching Greatness

Make Money in Global Health-Care Stocks the Easy Way

Our Top Biotech Stock Idea

Incyte Drug Cleared in the US - Analyst Blog

In Biotech, Approval's Important, but It's the Launch That Counts

Incyte Shares Popped: What You Need to Know

3 Stocks Near 52-Week Lows Worth Buying

Make Money in Health-Care Providers the Easy Way

10 Biotech Stocks Trading at Deep Discounts to Analyst Target Prices

Mini J&J? I Guess Not

7 FDA Decisions You Can't Afford to Ignore in Q4

Whoa! My Stock Crushed the Market!

Pfizer Poised to Introduce Blockbuster Arthritis Pill

Better Late Than Never? Maybe.

See More Articles...